• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

所有甲状旁腺功能亢进患者都应进行CDC73基因突变筛查吗?

Should all patients with hyperparathyroidism be screened for a CDC73 mutation?

作者信息

Bachmeier Caroline, Patel Chirag, Kanowski Peter, Sangla Kunwarjit

机构信息

Endocrinology Department, Townsville Hospital, Townsville, Queensland, Australia.

Genetic Health Queensland, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.

出版信息

Endocrinol Diabetes Metab Case Rep. 2018 Mar 8;2018. doi: 10.1530/EDM-17-0164. eCollection 2018.

DOI:10.1530/EDM-17-0164
PMID:29535865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5843797/
Abstract

UNLABELLED

Primary hyperparathyroidism (PH) is a common endocrine abnormality and may occur as part of a genetic syndrome. Inactivating mutations of the tumour suppressor gene have been identified as accounting for a large percentage of hyperparathyroidism-jaw tumour syndrome (HPT-JT) cases and to a lesser degree account for familial isolated hyperparathyroidism (FIHP) cases. Reports of whole gene deletions are exceedingly rare. We report the case of a 39 year-old woman with PH secondary to a parathyroid adenoma associated with a large chromosomal deletion (2.5 Mb) encompassing the entire gene detected years after parathyroidectomy. This case highlights the necessity to screen young patients with hyperparathyroidism for an underlying genetic aetiology. It also demonstrates that molecular testing for this disorder should contain techniques that can detect large deletions.

LEARNING POINTS

Necessity of genetic screening for young people with hyperparathyroidism.Importance of screening for large, including whole gene deletions.Surveillance for patients with gene mutations includes regular calcium and parathyroid hormone levels, dental assessments and imaging for uterine and renal tumours.

摘要

未标注

原发性甲状旁腺功能亢进症(PH)是一种常见的内分泌异常,可能作为遗传综合征的一部分出现。肿瘤抑制基因的失活突变已被确定在很大比例的甲状旁腺功能亢进-颌骨肿瘤综合征(HPT-JT)病例中起作用,在较小程度上也导致家族性孤立性甲状旁腺功能亢进症(FIHP)病例。关于整个基因缺失的报道极为罕见。我们报告了一例39岁女性,其PH继发于甲状旁腺腺瘤,伴有一个大的染色体缺失(2.5 Mb),该缺失包含整个基因,在甲状旁腺切除术后数年才被检测到。该病例强调了对年轻甲状旁腺功能亢进患者筛查潜在遗传病因的必要性。它还表明,针对这种疾病的分子检测应包含能够检测大缺失的技术。

学习要点

对年轻甲状旁腺功能亢进患者进行基因筛查的必要性。筛查大缺失(包括整个基因缺失)的重要性。对携带基因 突变的患者进行监测包括定期检测钙和甲状旁腺激素水平、牙科评估以及子宫和肾脏肿瘤的影像学检查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ff/5843797/94be9b67d772/edmcr-2018-170164-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ff/5843797/94be9b67d772/edmcr-2018-170164-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12ff/5843797/94be9b67d772/edmcr-2018-170164-g001.jpg

相似文献

1
Should all patients with hyperparathyroidism be screened for a CDC73 mutation?所有甲状旁腺功能亢进患者都应进行CDC73基因突变筛查吗?
Endocrinol Diabetes Metab Case Rep. 2018 Mar 8;2018. doi: 10.1530/EDM-17-0164. eCollection 2018.
2
-Related Disorders相关疾病
3
Large intragenic deletion of CDC73 (exons 4-10) in a three-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family.一个三代甲状旁腺功能亢进-颌骨肿瘤(HPT-JT)综合征家系中 CDC73(exon4-10)大片段基因内缺失。
BMC Med Genet. 2017 Aug 3;18(1):83. doi: 10.1186/s12881-017-0445-0.
4
Hyperparathyroidism-Jaw Tumor Syndrome Associated With Large-Scale 1q31 Deletion.与大规模1q31缺失相关的甲状旁腺功能亢进-颌骨肿瘤综合征
J Endocr Soc. 2017 May 25;1(7):926-930. doi: 10.1210/js.2016-1089. eCollection 2017 Jul 1.
5
Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese.中国人群中由CDC73基因种系大片段缺失或点突变引起的家族性孤立性原发性甲状旁腺功能亢进症/甲状旁腺功能亢进-颌骨肿瘤综合征
Clin Endocrinol (Oxf). 2014 Aug;81(2):222-30. doi: 10.1111/cen.12461. Epub 2014 May 6.
6
Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome.细胞分裂周期73基因缺失的小鼠会发生甲状旁腺和子宫肿瘤:一种甲状旁腺功能亢进-颌骨肿瘤综合征的模型。
Oncogene. 2017 Jul 13;36(28):4025-4036. doi: 10.1038/onc.2017.43. Epub 2017 Mar 13.
7
HIGH RISK OF PARATHYROID CARCINOMA AND GENETIC SCREENING IN THE FIRST DIAGNOSED ROMANIAN FAMILY WITH HYPERPARATHYROIDISM-JAW TUMOR SYNDROME AND A GERMLINE MUTATION OF THE CDC73 GENE.罗马尼亚首例诊断为甲状旁腺功能亢进-颌骨肿瘤综合征且携带CDC73基因种系突变的家族中甲状旁腺癌的高风险及基因筛查
Acta Endocrinol (Buchar). 2019 Jul-Sep;15(3):398-403. doi: 10.4183/aeb.2019.398.
8
Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.一名有甲状旁腺功能亢进-颌骨肿瘤综合征病史且已治愈的全身性骨纤维囊性骨炎患者的肿瘤抑制基因突变:病例报告及遗传病理生理学综述
J Oral Maxillofac Surg. 2015 Jan;73(1):194.e1-9. doi: 10.1016/j.joms.2014.09.008. Epub 2014 Sep 28.
9
Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism.CDC73相关家族性甲状旁腺功能亢进症的临床、遗传学及组织病理学研究
Endocr Relat Cancer. 2008 Dec;15(4):1115-26. doi: 10.1677/ERC-08-0066. Epub 2008 Aug 28.
10
A novel CDC73 gene mutation in an Italian family with hyperparathyroidism-jaw tumour (HPT-JT) syndrome.一个患有甲状旁腺功能亢进-颌骨肿瘤(HPT-JT)综合征的意大利家族中的一种新型CDC73基因突变。
Cell Oncol (Dordr). 2014 Aug;37(4):281-8. doi: 10.1007/s13402-014-0187-3. Epub 2014 Aug 12.

引用本文的文献

1
Clinical Features, Treatment, and Surveillance of Hyperparathyroidism-Jaw Tumor Syndrome: An Up-to-Date and Review of the Literature.甲状旁腺功能亢进-颌骨肿瘤综合征的临床特征、治疗及监测:文献综述与最新进展
Int J Endocrinol. 2019 Dec 18;2019:1761030. doi: 10.1155/2019/1761030. eCollection 2019.

本文引用的文献

1
Hyperparathyroidism-Jaw Tumor Syndrome Associated With Large-Scale 1q31 Deletion.与大规模1q31缺失相关的甲状旁腺功能亢进-颌骨肿瘤综合征
J Endocr Soc. 2017 May 25;1(7):926-930. doi: 10.1210/js.2016-1089. eCollection 2017 Jul 1.
2
Primary hyperparathyroidism in young patients in Russia: high frequency of hyperparathyroidism-jaw tumor syndrome.俄罗斯年轻患者中的原发性甲状旁腺功能亢进症:甲状旁腺功能亢进-颌骨肿瘤综合征的高发病率。
Endocr Connect. 2017 Nov;6(8):557-565. doi: 10.1530/EC-17-0126. Epub 2017 Sep 4.
3
Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.
原发性甲状旁腺功能亢进症:关于评估、诊断和管理的综述与建议。加拿大及国际共识。
Osteoporos Int. 2017 Jan;28(1):1-19. doi: 10.1007/s00198-016-3716-2. Epub 2016 Sep 9.
4
The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism.美国内分泌外科学会原发性甲状旁腺功能亢进症确定性治疗指南。
JAMA Surg. 2016 Oct 1;151(10):959-968. doi: 10.1001/jamasurg.2016.2310.
5
Hyperparathyroidism-jaw tumor syndrome: Results of operative management.甲状旁腺功能亢进-颌骨肿瘤综合征:手术治疗结果
Surgery. 2014 Dec;156(6):1315-24; discussion 1324-5. doi: 10.1016/j.surg.2014.08.004. Epub 2014 Oct 16.
6
Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism.法国原发性甲状旁腺功能亢进症患者的一个全国性队列中频繁出现大型种系 HRPT2 缺失。
J Clin Endocrinol Metab. 2013 Feb;98(2):E403-8. doi: 10.1210/jc.2012-2789. Epub 2013 Jan 4.
7
Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family.检测到一个 HPT-JT 综合征家族中的首个 CDC73 种系大片段缺失。
Genes Chromosomes Cancer. 2011 Nov;50(11):922-9. doi: 10.1002/gcc.20911. Epub 2011 Aug 11.
8
Identification of the first germline HRPT2 whole-gene deletion in a patient with primary hyperparathyroidism.在一名甲状旁腺功能亢进症患者中鉴定到首个种系 HRPT2 全基因缺失。
Clin Endocrinol (Oxf). 2012 Jan;76(1):33-8. doi: 10.1111/j.1365-2265.2011.04184.x.
9
Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors.细胞分裂周期蛋白 73 同源物(CDC73)突变与甲状旁腺功能亢进-颌骨肿瘤综合征(HPT-JT)和甲状旁腺瘤有关。
Hum Mutat. 2010 Mar;31(3):295-307. doi: 10.1002/humu.21188.
10
Hyperparathyroidism.甲状旁腺功能亢进症。
Lancet. 2009 Jul 11;374(9684):145-58. doi: 10.1016/S0140-6736(09)60507-9.